Arena Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Arena Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 4.58 million shares as of 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2022-02-23
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 4.58M shares.
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 4.41M shares.
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 4.27M shares.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 4.22M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number |
|---|---|
| 2021-12-31 | 4.58M shares 10-K · filed 2022-02-23 |
| 2021-09-30 | 4.41M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 4.27M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 4.22M shares 10-Q · filed 2021-05-05 |